nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—CYP1A2—chronic obstructive pulmonary disease	0.495	1	CbGaD
Lumiracoxib—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0968	0.222	CbGbCtD
Lumiracoxib—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0618	0.142	CbGbCtD
Lumiracoxib—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0618	0.142	CbGbCtD
Lumiracoxib—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0514	0.118	CbGbCtD
Lumiracoxib—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0514	0.118	CbGbCtD
Lumiracoxib—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0485	0.111	CbGbCtD
Lumiracoxib—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.039	0.0892	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.026	0.0595	CbGbCtD
Lumiracoxib—Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.00177	0.336	CrCbGaD
Lumiracoxib—Tolmetin—MPO—chronic obstructive pulmonary disease	0.00138	0.261	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—chronic obstructive pulmonary disease	0.000973	0.185	CrCbGaD
Lumiracoxib—Diclofenac—CYP1A1—chronic obstructive pulmonary disease	0.000454	0.0863	CrCbGaD
Lumiracoxib—Diclofenac—CYP1A2—chronic obstructive pulmonary disease	0.000438	0.0832	CrCbGaD
Lumiracoxib—Diclofenac—ALB—chronic obstructive pulmonary disease	0.000253	0.0481	CrCbGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00346	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000211	0.00336	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00021	0.00335	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00335	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00332	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000207	0.0033	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000206	0.00328	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00324	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000197	0.00314	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00312	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000192	0.00306	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00305	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.003	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.00299	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00296	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000185	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000183	0.00291	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000179	0.00286	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000177	0.00282	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00276	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000169	0.0027	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000169	0.0027	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000167	0.00267	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00266	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000166	0.00264	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000166	0.00264	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000165	0.00263	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000164	0.00261	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000159	0.00254	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000158	0.00252	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00251	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000157	0.00251	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000155	0.00247	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00245	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00242	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00238	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00235	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000144	0.0023	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0023	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0023	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0023	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000142	0.00227	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000142	0.00226	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00014	0.00224	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000137	0.00219	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00218	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00217	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00215	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00215	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00214	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000134	0.00214	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.0021	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.00013	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00013	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00013	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000128	0.00204	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00193	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000119	0.0019	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000118	0.00188	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00186	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00183	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000112	0.00179	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00178	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00176	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.00011	0.00176	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000107	0.00171	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.0017	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000106	0.00168	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00168	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000104	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.00164	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000103	0.00164	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000103	0.00164	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000102	0.00163	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000102	0.00162	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	9.83e-05	0.00157	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.71e-05	0.00155	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	9.68e-05	0.00154	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.6e-05	0.00153	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	9.55e-05	0.00152	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.0015	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	9.04e-05	0.00144	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	8.97e-05	0.00143	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.85e-05	0.00141	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.73e-05	0.00139	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	8.38e-05	0.00134	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.3e-05	0.00132	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.2e-05	0.00131	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.07e-05	0.00129	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.96e-05	0.00127	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.96e-05	0.00127	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.85e-05	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	7.66e-05	0.00122	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.49e-05	0.00119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.38e-05	0.00118	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.29e-05	0.00116	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.28e-05	0.00116	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.23e-05	0.00115	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	7.12e-05	0.00114	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	7.09e-05	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	6.9e-05	0.0011	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.83e-05	0.00109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.78e-05	0.00108	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.74e-05	0.00108	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.73e-05	0.00107	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	6.71e-05	0.00107	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.69e-05	0.00107	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.64e-05	0.00106	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	6.62e-05	0.00106	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.6e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.43e-05	0.00103	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.4e-05	0.00102	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.34e-05	0.00101	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	6.25e-05	0.000996	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.19e-05	0.000987	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.000987	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.18e-05	0.000985	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.1e-05	0.000973	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.08e-05	0.000969	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.07e-05	0.000968	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.07e-05	0.000968	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.94e-05	0.000948	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.9e-05	0.00094	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000935	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.83e-05	0.000931	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.78e-05	0.000923	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	5.78e-05	0.000922	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.78e-05	0.000922	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.78e-05	0.000922	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.75e-05	0.000918	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.67e-05	0.000905	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.38e-05	0.000858	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.29e-05	0.000843	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.25e-05	0.000838	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.21e-05	0.000832	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.17e-05	0.000825	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	5.15e-05	0.000821	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.08e-05	0.00081	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	5.05e-05	0.000805	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.01e-05	0.000799	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.000788	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.9e-05	0.000782	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	4.81e-05	0.000767	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.72e-05	0.000753	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.72e-05	0.000753	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.68e-05	0.000747	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	4.59e-05	0.000732	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.28e-05	0.000683	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.27e-05	0.000681	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	4.24e-05	0.000676	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.03e-05	0.000643	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	3.88e-05	0.000619	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.88e-05	0.000618	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.83e-05	0.000611	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.81e-05	0.000609	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.69e-05	0.000589	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.57e-05	0.00057	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.5e-05	0.000559	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.5e-05	0.000558	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.43e-05	0.000548	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.000547	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.000542	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.4e-05	0.000542	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.36e-05	0.000537	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.33e-05	0.000532	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.27e-05	0.000522	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.000514	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-05	0.000504	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.13e-05	0.000499	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.12e-05	0.000498	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.1e-05	0.000494	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000494	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.04e-05	0.000485	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.91e-05	0.000464	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.88e-05	0.00046	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.87e-05	0.000459	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000455	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.83e-05	0.000451	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.000429	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000426	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.65e-05	0.000423	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-05	0.000419	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.6e-05	0.000414	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	2.52e-05	0.000402	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.51e-05	0.0004	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.48e-05	0.000395	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000394	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000394	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.42e-05	0.000385	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000373	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KL—chronic obstructive pulmonary disease	2.34e-05	0.000373	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000369	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000361	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000359	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-05	0.000349	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-05	0.000345	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.08e-05	0.000332	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.01e-05	0.000321	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.000307	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.000304	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000291	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.000287	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.75e-05	0.00028	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.71e-05	0.000273	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000268	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000265	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000262	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000262	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.000255	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.59e-05	0.000254	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000244	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.52e-05	0.000243	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.000242	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000241	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000239	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.46e-05	0.000233	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000226	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000224	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.00022	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000209	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-05	0.000207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000204	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000201	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000199	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000198	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.23e-05	0.000196	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000185	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000184	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.000181	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000175	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000169	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000164	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.00016	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.85e-06	0.000157	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.84e-06	0.000157	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.7e-06	0.000155	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.04e-06	0.000144	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.57e-06	0.000137	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	7.78e-06	0.000124	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	7.62e-06	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.48e-06	0.000119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.15e-06	0.000114	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.82e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.52e-06	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	5.86e-06	9.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.83e-06	9.29e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.57e-06	8.89e-05	CbGpPWpGaD
